STOCK TITAN

Zebra Technologies Corporation Form 4 Filings

ZBRA NASDAQ

Every Form 4 that Zebra Technologies Corporation (ZBRA) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ZBRA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ZBRA filings page.

Rhea-AI Summary

Zebra Technologies Corporation Chief Financial Officer Nathan Andrew Winters reported an equity award tied to earlier performance-based restricted stock. On February 3, 2026, he acquired 4,073 shares of Class A common stock at $0 per share, following completion of a three-year performance period.

After this award, Winters directly beneficially owns 19,504 shares of Class A common stock. He also directly holds stock appreciation rights covering 315 shares at $205.12 per share expiring on May 2, 2026, and 578 shares at $244.97 per share expiring on April 30, 2027. The PVRS are scheduled to vest on May 4, 2026.

Rhea-AI Summary

Zebra Technologies’ Chief Marketing Officer reports new equity grant. On February 3, 2026, Robert John Armstrong Jr received 841 shares of Class A Common Stock at a price of $0, stemming from a performance-based restricted stock (PVRS) award granted on May 4, 2023.

The three-year performance period for this PVRS ended on December 31, 2025, and the final share number was determined on February 3, 2026. The PVRS is scheduled to vest on May 4, 2026. After this transaction, Armstrong directly beneficially owned 6,053 Class A Common shares. He also directly holds stock appreciation rights tied to 166 and 198 underlying Class A shares, which became exercisable in four equal annual installments starting in 2020 and 2021, respectively.

Rhea-AI Summary

Zebra Technologies’ Chief Supply Chain Officer Tamara Dionne Froese reported a new equity award. On February 3, 2026, she acquired 787 shares of Zebra Class A common stock at a price of $0, reflecting performance-based restricted stock from a May 4, 2023 PVRS grant. Following this transaction, she directly owned 5,177 Class A shares, which include 63 shares purchased through Zebra’s Employee Stock Purchase Plan in 2025. She also held stock appreciation rights tied to 328 shares of Class A common stock, which became exercisable in four equal annual installments beginning April 30, 2021.

Rhea-AI Summary

Zebra Technologies’ Chief Strategy Officer Michael Cho reported an equity award in the company’s Class A common stock. On February 3, 2026, he acquired 1,575 shares at $0 per share, reflecting settlement of a performance-based restricted stock (PVRS) grant originally awarded on May 4, 2023.

The PVRS covered a three-year performance period that ended on December 31, 2025, with the final share amount determined on February 3, 2026. These PVRS are scheduled to vest on May 4, 2026. Following this transaction, Cho directly beneficially owned 6,957 Class A common shares.

Rhea-AI Summary

Zebra Technologies director reports open-market stock purchases. A company director filed a Form 4 showing two purchases of Class A common stock of Zebra Technologies Corporation (ticker ZBRA) on 11/18/2025. One transaction added 701 shares at a weighted average price of $232.90, and a second added 299 shares at a weighted average price of $233.63. After these transactions, the director beneficially owns 3,356 shares of Zebra Technologies Class A common stock held directly.

The prices reported are weighted averages, as the shares were bought in multiple trades within narrow price ranges around the stated amounts.

Rhea-AI Summary

Zebra Technologies (ZBRA) reported a Form 4 by its Chief Revenue Officer. On 11/03/2025, a Code F transaction disposed of 759 shares of Class A common stock at $270.58, leaving 6,058 shares beneficially owned directly.

The filing also lists 189 stock appreciation rights with a $244.97 exercise price, expiring 04/30/2027; these became exercisable in four equal annual installments beginning 04/30/2021.